{
    "title": "Early research suggests Merck cancer drug may target dormant HIV",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10446159/Early-research-suggests-Merck-cancer-drug-target-dormant-HIV.html",
    "date": "2022-01-27",
    "keywords": [
        "hiv",
        "cancer",
        "immune",
        "pembrolizumab",
        "virus",
        "study",
        "infection",
        "system",
        "keytruda",
        "treatment",
        "bodys",
        "work",
        "way",
        "research",
        "professor",
        "jan",
        "merck",
        "amp",
        "co",
        "drug",
        "immunotherapy",
        "area",
        "body",
        "antibody",
        "protein",
        "death",
        "receptor",
        "pd1",
        "collaboration",
        "evidence",
        "latency",
        "ability",
        "therapy",
        "wednesday",
        "science",
        "medicine",
        "hutchinson",
        "center",
        "reservoir",
        "sharon",
        "director",
        "peter",
        "doherty",
        "institute",
        "immunity",
        "statement",
        "group",
        "blood",
        "lewin",
        "response",
        "reporting",
        "deena",
        "beasley",
        "editing",
        "cynthia",
        "osterman"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}